[HTML][HTML] Treatment decisions for advanced non-squamous non-small cell lung cancer: patient and physician perspectives on maintenance therapy
S McMullen, LM Hess, ES Kim, B Levy… - The Patient-Patient …, 2019 - Springer
Introduction Advanced non-small cell lung cancer (NSCLC) is a severe disease with
burdensome symptoms and traditionally poor outcomes. The treatment of advance disease …
burdensome symptoms and traditionally poor outcomes. The treatment of advance disease …
Treatment Decisions for Advanced Non‑Squamous Non‑Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy
S McMullen, LM Hess, ES Kim, B Levy… - The …, 2019 - search.proquest.com
Introduction Advanced non-small cell lung cancer (NSCLC) is a severe disease with
burdensome symptoms and traditionally poor outcomes. The treatment of advance disease …
burdensome symptoms and traditionally poor outcomes. The treatment of advance disease …
Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy
S McMullen, LM Hess, ES Kim, B Levy… - The Patient: Patient …, 2019 - ideas.repec.org
Introduction Advanced non-small cell lung cancer (NSCLC) is a severe disease with
burdensome symptoms and traditionally poor outcomes. The treatment of advance disease …
burdensome symptoms and traditionally poor outcomes. The treatment of advance disease …
Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy
S McMullen, LM Hess, ES Kim, B Levy… - The Patient: Patient …, 2019 - econpapers.repec.org
Introduction Advanced non-small cell lung cancer (NSCLC) is a severe disease with
burdensome symptoms and traditionally poor outcomes. The treatment of advance disease …
burdensome symptoms and traditionally poor outcomes. The treatment of advance disease …
Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy
S McMullen, LM Hess, ES Kim, B Levy, M Mohamed… - Patient, 2019 - pure.johnshopkins.edu
Introduction: Advanced non-small cell lung cancer (NSCLC) is a severe disease with
burdensome symptoms and traditionally poor outcomes. The treatment of advance disease …
burdensome symptoms and traditionally poor outcomes. The treatment of advance disease …
Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy
S McMullen, LM Hess, ES Kim, B Levy… - The …, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction Advanced non-small cell lung cancer (NSCLC) is a severe disease with
burdensome symptoms and traditionally poor outcomes. The treatment of advance disease …
burdensome symptoms and traditionally poor outcomes. The treatment of advance disease …
Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy.
S McMullen, LM Hess, ES Kim, B Levy, M Mohamed… - The Patient, 2019 - europepmc.org
Results Interviewed patients (n= 10) were motivated to receive MT in the hope of extending
their lives and being proactive against their cancer, and they anticipated reduced adverse …
their lives and being proactive against their cancer, and they anticipated reduced adverse …
[HTML][HTML] Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy
S McMullen, LM Hess, ES Kim, B Levy, M Mohamed… - The Patient, 2019 - ncbi.nlm.nih.gov
Results Interviewed patients (n= 10) were motivated to receive MT in the hope of extending
their lives and being proactive against their cancer, and they anticipated reduced adverse …
their lives and being proactive against their cancer, and they anticipated reduced adverse …
Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy.
S McMullen, LM Hess, ES Kim, B Levy, M Mohamed… - The Patient, 2019 - europepmc.org
Results Interviewed patients (n= 10) were motivated to receive MT in the hope of extending
their lives and being proactive against their cancer, and they anticipated reduced adverse …
their lives and being proactive against their cancer, and they anticipated reduced adverse …